
ISMRC/LinkedIn
Apr 30, 2025, 11:45
ISMRC 2025: Christoffer Gebhardt to Present on ctDNA and Immunotherapy in Melanoma
International Symposium on Minimal Residual Cancer shared on LinkedIn:
“Professor Christoffer Gebhardt (University Medical Center Hamburg-Eppendorf), Vice Chair of Dermatology and Head of the University Skin Cancer Center Hamburg, is pushing the boundaries of melanoma treatment through ctDNA profiling and biomarker-driven immunotherapy. Catch his insights at ISMRC 2025 in the Liquid Biopsy and Immunotherapy session.
The ISMRC 2025 is organized by Paul Hofman, Catherine Alix-Panabières and Klaus Pantel.”
Explore more about Immunotherapy in Melanoma on OncoDaily:
“Immunotherapy for Melanoma: Types, Success Rate, Side Effects & More”
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Apr 30, 2025, 11:15
Apr 30, 2025, 11:02
Apr 30, 2025, 10:53
Apr 30, 2025, 10:36
Apr 30, 2025, 10:26
Apr 30, 2025, 10:19